Ann Arbor, MI
ONL Therapeutics, Inc. operates as a biopharmaceutical company. The Company develops drugs for the treatment of serious, vision-threatening retinal diseases, and conditions including retinal detachment and wet and dry forms of age-related macular degeneration. ONL Therapeutics serves patients in the United States.
onltherapeutics.comThese are collections ONL Therapeutics is a part of. Click on the collection name to view similar companies.
Series D
$65,000,000
Series Unknown
$9,999,948
Series C
$15,000,000
Series B
$46,900,000
Convertible Note
$3,000,000
Series A
$4,250,000
Grant
$1,000,000
Debt Financing
$916,161
Grant
$1,370,000
Seed
$501,810
0 out of 5 stars
Based on 0 reviews
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on ONL Therapeutics.